A membrane-bound vaccinia viral protein 'mem35k' blocks CC-chemokine induced cell migration and CC-chemokine activity in vitro

A membrane-bound vaccinia viral protein 'mem35k' blocks CC-chemokine induced cell migration and CC-chemokine activity in vitro

Bibliographic Details
Main Authors:	Bursill, C, Greaves, D, Channon, K
Format:	Conference item
Published:	2005

Similar Items

Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2006)

Adenoviral mediated delivery of a vaccinia viral protein (35K) blocks CC-chemokine activity in vitro and in vivo and may therefore be a useful therapeutic strategy to reduce the initiation and progression of CC-chemokine induced atherosclerosis
by: Bursill, C, et al.
Published: (2003)

Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2003)

Adenoviral delivery of CC-chemokine inhibitor '35K' reduces macrophage recruitment and atherosclerosis in ApoE knockout mice
by: Bursill, C, et al.
Published: (2004)

Expression of a membrane associated CC-chemokine inhibitor protein reduces in vitro macrophage chemotaxis to CC chemokines
by: McNeill, E, et al.
Published: (2010)

Adenoviral-mediated delivery of a CC-chemokine inhibitor ('35K') attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
by: Bursill, C, et al.
Published: (2004)

Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.
by: White, G, et al.
Published: (2011)

Adenoviral delivery of a Cc-chemokine inhibitor, "35k," reduces macrophage recruitment and atherosclerosis in Apoe knockout mice
by: Bursill, C, et al.
Published: (2004)

Adenoviral mediated delivery of a CC chemokine (CK) inhibitor ("35K") attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
by: Bursill, C, et al.
Published: (2004)

Generation and site-directed mutagenesis of a 35K-Fc fusion protein with increased potency of CC chemokine blockade
by: White, G, et al.
Published: (2010)

Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition.
by: Bursill, C, et al.
Published: (2009)

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
by: Jan Korbecki, et al.
Published: (2020-08-01)

The roles of CC chemokines in response to radiation
by: Lei Wang, et al.
Published: (2022-04-01)

Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
by: Bursill, C, et al.
Published: (2004)

Broad spectrum adenoviral CC-chemokine blockade attenuates long term vein graft accelerated atherosclerosis in ApoE-knockout mice
by: Ali, Z, et al.
Published: (2007)

Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
by: Ali, Z, et al.
Published: (2005)

CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
by: White, G, et al.
Published: (2013)

Adenoviral gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice
by: Ali, Z, et al.
Published: (2004)

Expression of Membrane-Bound CC Chemokine Ligand 20 on Follicular T Helper Cells in T–B-Cell Conjugates
by: Adrian Y. S. Lee, et al.
Published: (2017-12-01)

Contrasting in vitro vs. in vivo effects of a cell membrane-specific CC-chemokine binding protein on macrophage chemotaxis.
by: McNeill, E, et al.
Published: (2014)

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
by: Dawei Sun, et al.
Published: (2023-12-01)

Role of CC-chemokine ligand 2 in gynecological cancer
by: Jia-Jia Zhang, et al.
Published: (2022-11-01)

Hydrodynamic gene delivery of CC chemokine binding Fc fusion proteins to target acute vascular inflammation in vivo.
by: McNeill, E, et al.
Published: (2015)

CC chemokines and receptors in osteoarthritis: new insights and potential targets
by: Yuchen Zhang, et al.
Published: (2023-07-01)

Epigenetic regulation of CC-chemokine ligand 2 in nonresolving inflammation
by: Kiguchi Norikazu, et al.
Published: (2014-08-01)

Gene transfer of a broad spectrum CC-chemokine inhibitor reduces macrophage recruitment and smooth muscle content in vein graft atherosclerosis in apolipoprotein E-knockout mice
by: Ali, Z, et al.
Published: (2005)

CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma
by: Wan-Hang Zhou, et al.
Published: (2022-07-01)

Chemokines, chemokine receptors and atherosclerosis
by: John, A, et al.
Published: (2005)

CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
by: Shanshan Liu, et al.
Published: (2023-02-01)

Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder
by: Gao W, et al.
Published: (2022-10-01)

Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
by: Maria E. Reyes, et al.
Published: (2020-05-01)

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
by: Assunta Venuti, et al.
Published: (2017-10-01)

CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration
by: Xinghe Liao, et al.
Published: (2024-01-01)

Dissecting the cytomegalovirus CC chemokine: Chemokine activity and gHgLchemokine-dependent cell tropism are independent players in CMV infection.
by: Marwa Eletreby, et al.
Published: (2023-12-01)

The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.
by: Bursill, C, et al.
Published: (2004)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
by: Wei, Z, et al.
Published: (2005)

Hepatic CC chemokines control the magnitude of the inflammatory response within the injured rodent brain
by: Campbell, S, et al.
Published: (2004)

Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment
by: Xinyuan Liu, et al.
Published: (2023-04-01)

CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
by: Joanna Bogacka, et al.
Published: (2022-12-01)

CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance
by: Zhenbo Shi, et al.
Published: (2022-08-01)